IL259214B - Substituted tricyclic 1,4-benzodiazepinone derivatives as allosteric modulators of group ii metabotropic glutamate receptors - Google Patents
Substituted tricyclic 1,4-benzodiazepinone derivatives as allosteric modulators of group ii metabotropic glutamate receptorsInfo
- Publication number
- IL259214B IL259214B IL259214A IL25921418A IL259214B IL 259214 B IL259214 B IL 259214B IL 259214 A IL259214 A IL 259214A IL 25921418 A IL25921418 A IL 25921418A IL 259214 B IL259214 B IL 259214B
- Authority
- IL
- Israel
- Prior art keywords
- group
- metabotropic glutamate
- glutamate receptors
- allosteric modulators
- substituted tricyclic
- Prior art date
Links
- RGGLEJFUEMKQSH-UHFFFAOYSA-N 1,4-benzodiazepin-2-one Chemical class O=C1C=NC=C2C=CC=CC2=N1 RGGLEJFUEMKQSH-UHFFFAOYSA-N 0.000 title 1
- 102000016193 Metabotropic glutamate receptors Human genes 0.000 title 1
- 108010010914 Metabotropic glutamate receptors Proteins 0.000 title 1
- 230000003281 allosteric effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15194611 | 2015-11-13 | ||
| PCT/GB2016/053550 WO2017081483A1 (en) | 2015-11-13 | 2016-11-11 | Substituted tricyclic 1,4-benzodiazepinone derivatives as allosteric modulators of group ii metabotropic glutamate receptors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL259214A IL259214A (en) | 2018-07-31 |
| IL259214B true IL259214B (en) | 2021-09-30 |
Family
ID=54542126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL259214A IL259214B (en) | 2015-11-13 | 2018-05-08 | Substituted tricyclic 1,4-benzodiazepinone derivatives as allosteric modulators of group ii metabotropic glutamate receptors |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11008323B2 (enExample) |
| EP (1) | EP3374360A1 (enExample) |
| JP (1) | JP7100362B2 (enExample) |
| KR (1) | KR20180097542A (enExample) |
| CN (1) | CN108834415B (enExample) |
| AU (1) | AU2016354661B2 (enExample) |
| BR (1) | BR112018009550A2 (enExample) |
| CA (1) | CA3004680A1 (enExample) |
| IL (1) | IL259214B (enExample) |
| WO (1) | WO2017081483A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110769830A (zh) * | 2017-05-12 | 2020-02-07 | 马瓦隆治疗有限公司 | 作为ii组代谢型谷氨酸受体的别构调节剂的取代的杂环化合物 |
| CN108084187A (zh) * | 2017-12-15 | 2018-05-29 | 宜昌人福药业有限责任公司 | 苯并二氮杂*类氢化物 |
| CN108003164A (zh) * | 2017-12-15 | 2018-05-08 | 宜昌人福药业有限责任公司 | 苯并二氮杂*类化合物 |
| WO2020223701A1 (en) * | 2019-05-02 | 2020-11-05 | The Broad Institute, Inc. | Methods for treating neurodevelopmental disorders |
| CN110172068A (zh) * | 2019-06-05 | 2019-08-27 | 河南龙湖生物技术有限公司 | 具有抗肿瘤活性的苯并噻唑类化合物及其制备方法和应用 |
| WO2021226208A2 (en) | 2020-05-05 | 2021-11-11 | Nuvalent, Inc. | Heteroaromatic macrocyclic ether chemotherapeutic agents |
| KR102698413B1 (ko) | 2020-05-05 | 2024-08-26 | 뉴베일런트, 아이엔씨. | 헤테로방향족 거대환식 에터 화학치료제 |
| TW202320768A (zh) | 2021-10-01 | 2023-06-01 | 美商努法倫特公司 | 雜芳族大環醚化合物之固體形式、醫藥組成物及製備 |
| WO2026006700A1 (en) * | 2024-06-28 | 2026-01-02 | Regents Of The University Of Michigan | Pyrrolo[1,2-a]-azocine analogues as iap antagonists |
| CN118993997A (zh) * | 2024-10-23 | 2024-11-22 | 浙江雅辰药物科技股份有限公司 | 一种3-溴-2-苯基吡啶的制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4130716A (en) | 1977-03-07 | 1978-12-19 | Hoffmann-La Roche Inc. | Pyrazolo benzodiazepines |
| US4263428A (en) | 1978-03-24 | 1981-04-21 | The Regents Of The University Of California | Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same |
| DE3169595D1 (en) | 1980-11-10 | 1985-05-02 | Gersonde Klaus | Method of preparing lipid vesicles by ultrasonic treatment, the use of this method and apparatus for its application |
| US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
| EP0088046B1 (de) | 1982-02-17 | 1987-12-09 | Ciba-Geigy Ag | Lipide in wässriger Phase |
| DE3218121A1 (de) | 1982-05-14 | 1983-11-17 | Leskovar, Peter, Dr.-Ing., 8000 München | Arzneimittel zur tumorbehandlung |
| EP0102324A3 (de) | 1982-07-29 | 1984-11-07 | Ciba-Geigy Ag | Lipide und Tenside in wässriger Phase |
| US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
| HUT35524A (en) | 1983-08-02 | 1985-07-29 | Hoechst Ag | Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance |
| DE3486459D1 (de) | 1983-09-26 | 1997-12-11 | Udo Dr Med Ehrenfeld | Mittel und Erzeugnis für die Diagnose und Therapie von Tumoren sowie zur Behandlung von Schwächen der zelligen und humoralen Immunabwehr |
| EP0143949B1 (en) | 1983-11-01 | 1988-10-12 | TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION | Pharmaceutical composition containing urokinase |
| FI880814A7 (fi) | 1987-03-10 | 1988-09-11 | Hoffmann La Roche | Imidazodiazepin-derivat. |
| MX2009007053A (es) | 2006-12-28 | 2009-07-09 | Abbott Lab | Inhibidores de poli (adp-ribosa) polimerasa. |
| US10059671B2 (en) | 2013-02-04 | 2018-08-28 | Prexton Therapeutics Sa | Positive allosteric modulators of mGluR3 |
-
2016
- 2016-11-11 CA CA3004680A patent/CA3004680A1/en not_active Abandoned
- 2016-11-11 AU AU2016354661A patent/AU2016354661B2/en not_active Ceased
- 2016-11-11 JP JP2018544438A patent/JP7100362B2/ja not_active Expired - Fee Related
- 2016-11-11 EP EP16797625.7A patent/EP3374360A1/en not_active Withdrawn
- 2016-11-11 KR KR1020187016380A patent/KR20180097542A/ko not_active Ceased
- 2016-11-11 CN CN201680078195.9A patent/CN108834415B/zh not_active Expired - Fee Related
- 2016-11-11 WO PCT/GB2016/053550 patent/WO2017081483A1/en not_active Ceased
- 2016-11-11 BR BR112018009550A patent/BR112018009550A2/pt not_active Application Discontinuation
- 2016-11-11 US US15/775,725 patent/US11008323B2/en not_active Expired - Fee Related
-
2018
- 2018-05-08 IL IL259214A patent/IL259214B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20180346468A1 (en) | 2018-12-06 |
| JP2019504108A (ja) | 2019-02-14 |
| BR112018009550A2 (pt) | 2018-11-06 |
| EP3374360A1 (en) | 2018-09-19 |
| JP7100362B2 (ja) | 2022-07-13 |
| AU2016354661B2 (en) | 2020-12-10 |
| CA3004680A1 (en) | 2017-05-18 |
| CN108834415B (zh) | 2021-12-24 |
| IL259214A (en) | 2018-07-31 |
| AU2016354661A1 (en) | 2018-06-07 |
| KR20180097542A (ko) | 2018-08-31 |
| US11008323B2 (en) | 2021-05-18 |
| WO2017081483A1 (en) | 2017-05-18 |
| CN108834415A (zh) | 2018-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL259214A (en) | Transformed tricyclic derivatives of 1,4-benzodiazepine as modulatory modulators of receptors of metabotropic glutamate group II | |
| IL282167A (en) | Metabolized carbonucleosides and their use for cancer treatment | |
| IL255096A0 (en) | Ethinylestradiol as metabotropic glutamate receptor modulators | |
| ZA201906104B (en) | Substituted imidazo-quinolines as nlrp3 modulators | |
| IL272888A (en) | Uses of piperidinyl-indole derivatives | |
| IL254769A0 (en) | Nitrobenzyl history of anticancer agents | |
| EP3137074A4 (en) | Prostaglandin receptor ep2 antagonists, derivatives, compositions, and uses related thereto | |
| ME03571B (me) | Fluoroindol derivati kao pozitivni alosterički modulatori muskarinskog m1 receptora | |
| IL251230A0 (en) | Converted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group ii metabotropic glutamate receptors | |
| IL250287A0 (en) | A new derivative of chromone oxime and its use as an allosteric modulator of metabotropic glutamate receptors | |
| ZA201803520B (en) | Indane derivatives as mglur7 modulators | |
| HK1260930A1 (en) | Substituted tricyclic 1,4-benzodiazepinone derivatives as allosteric modulators of group ii metabotropic glutamate receptors | |
| EP3285873A4 (en) | Substituted benzofuran derivatives as novel antimycobacterial agents | |
| HK40017272A (en) | Substituted heterocyclic compounds as allosteric modulators of group ii metabotropic glutamate receptors | |
| HK1240212A1 (en) | Substituted bridged urea analogs as sirtuin modulators | |
| AU2015905333A0 (en) | Modulators of Endosomal G Protein-Coupled Receptors |